ArticleJournal of gastrointestinal cancer2026
Real-world Predictors of Early Mortality and Treatment Discontinuation in HCC Patients Treated with Atezolizumab-Bevacizumab.
Palma Fedele et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it